Riskpilot← Back to searchSign inGet full accessHelseplan Nysam AB
ABActiveOrg 5567619464Drottninggatan 97Business and other management consultancy activities · NACE 7020Est. 20083 employees
Revenue 2025
SEK 7,3M
-2% vs 2024
EBITDA margin
21.1%
+92% vs 2024
Equity ratio
78.6%
Financial strength
Net profit 2025
SEK 1,2M
+89% vs 2024
| Revenue | SEK 7,3M | -2% |
| EBITDA | SEK 1,6M | +92% |
| Net profit | SEK 1,2M | +89% |
| Total assets | SEK 5,2M | +36% |
| Equity | SEK 4,1M | +43% |
| Employees | 3 | — |
Legal name
Helseplan Nysam AB
Org number
5567619464
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
8 juli 2008
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är konsultverksamhet inom hälsa, sjukvård och omsorg samt därmed förenlig verksamhet.
Address
Drottninggatan 97
Phone
+46841040800
Email
amanda.gyllensward@helseplan.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 466 | 7 490 | 8 958 | 7 509 | 7 350 |
| Staff expenses | — | — | — | −3 332 | −2 911 |
| EBITDA | −749 | 1 067 | 1 209 | 806 | 1 550 |
| Depreciation & amort. | −0 | −0 | −0 | −1 | −6 |
| EBIT | −749 | 1 067 | 1 209 | 804 | 1 544 |
| Net financials | — | — | 22 | 18 | 2 |
| Profit before tax | −749 | 1 067 | 1 230 | 823 | 1 546 |
| Tax | −0 | −100 | −265 | −175 | −322 |
| Net profit | −749 | 967 | 965 | 648 | 1 224 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 992 | 5 079 | 6 167 | 3 812 | 5 173 |
| Equity | 2 960 | 3 927 | 4 892 | 2 839 | 4 064 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 2 032 | 1 153 | 1 275 | 972 | 1 109 |
| Total debt | 2 032 | 1 153 | 1 275 | 972 | 1 109 |
EBITDA margin
21.1%
This company
15.8%
Market median
+34% vs market
20212025
Equity ratio
78.6%
This company
38.2%
Market median
+106% vs market
20212025
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20212025
Net profit margin
16.7%
This company
8.1%
Market median
+106% vs market
20212025
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20212025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2020 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Helseplan Consulting Group AB
Helseplan Nysam AB Board members of Helseplan Nysam AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Olof Anders Johansson Sjödin | Audit | 0 companies |
| Erik Niklas Källberg | Board of Directors | 0 companies |
| Pär David Ahlborg | Deputy Board Member | 0 companies |
| Amanda Göransdotter Gyllenswärd | Chairman | 0 companies |
| Kristina Sofie Nilsson | Deputy Board Member | 0 companies |